Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide, published by Digital Health Agency (DHA), Kenya. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/IntelliSOFT-Consulting/nccpFHIRIG/ and changes regularly. See the Directory of published versions
<Procedure xmlns="http://hl7.org/fhir">
<id value="PriorRadiotherapyProcedureExample"/>
<meta>
<profile
value="https://nshr-uat.sha.go.ke/fhir/StructureDefinition/nccp-prior-radiotherapy-procedure"/>
</meta>
<language value="en"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: Procedure PriorRadiotherapyProcedureExample</b></p><a name="PriorRadiotherapyProcedureExample"> </a><a name="hcPriorRadiotherapyProcedureExample"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-nccp-prior-radiotherapy-procedure.html">NCCP Prior Radiotherapy Procedure</a></p></div><p><b>status</b>: Completed</p><p><b>category</b>: <span title="Codes:{https://nshr-uat.sha.go.ke/fhir/CodeSystem/sha-interventions-cs SHA-RT-CONCURRENT-CRT}">SHA: Concurrent Chemo-Radiotherapy</span></p><p><b>code</b>: <span title="Codes:{https://nshr-uat.sha.go.ke/fhir/CodeSystem/sha-interventions-cs SHA-RT-CONCURRENT-CRT}">SHA: Concurrent Chemo-Radiotherapy</span></p><p><b>subject</b>: <a href="Patient-example-patient.html">Mary Wanjiku Female, DoB: 1975-06-15</a></p><p><b>performed</b>: 2023-03-01 --> 2023-04-15</p><p><b>bodySite</b>: <span title="Codes:{https://nshr-uat.sha.go.ke/fhir/CodeSystem/cancer-primary-site-cs CERVIX-UTERI}">Cervix Uteri</span></p><p><b>note</b>: </p><blockquote><div><p>External beam RT 45 Gy/25 fractions plus brachytherapy boost. Concurrent weekly cisplatin 40 mg/m².</p>
</div></blockquote></div>
</text>
<status value="completed"/>
<category>
<coding>
<system
value="https://nshr-uat.sha.go.ke/fhir/CodeSystem/sha-interventions-cs"/>
<code value="SHA-RT-CONCURRENT-CRT"/>
<display value="SHA: Concurrent Chemo-Radiotherapy"/>
</coding>
</category>
<code>
<coding>
<system
value="https://nshr-uat.sha.go.ke/fhir/CodeSystem/sha-interventions-cs"/>
<code value="SHA-RT-CONCURRENT-CRT"/>
<display value="SHA: Concurrent Chemo-Radiotherapy"/>
</coding>
</code>
<subject>🔗
<reference value="Patient/example-patient"/>
</subject>
<performedPeriod>
<start value="2023-03-01"/>
<end value="2023-04-15"/>
</performedPeriod>
<bodySite>
<coding>
<system
value="https://nshr-uat.sha.go.ke/fhir/CodeSystem/cancer-primary-site-cs"/>
<code value="CERVIX-UTERI"/>
<display value="Cervix Uteri"/>
</coding>
</bodySite>
<note>
<text
value="External beam RT 45 Gy/25 fractions plus brachytherapy boost. Concurrent weekly cisplatin 40 mg/m²."/>
</note>
</Procedure>